Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia, Europe, and North and South America. The aim of this
clinical trial is to investigate the safety and efficacy of turoctocog alfa (recombinant
factor VIII, rFVIII (N8)) in male previously treated paediatric subjects with haemophilia A.